Signaling pathway triggered by a short immunomodulating peptide on human monocytes
López-Zabalza MJ, Martínez-Lausín S, Bengoechea-Alonso MT, López-Moratalla N, González A [ES], Santiago E.
Department of Biochemistry, University of Navarra, Pamplona, Spain.
Revisão:Archives of Biochemistry and Biophysics
Data: 15/Fev/1997Bioquímica Clínica [ES]
A short synthetic peptide (Pa) containing a structural motif (2-6-11 motif) present in a number of human extracellular matrix proteins was found to stimulate the production of cytokines IL-1alpha, IL-1beta, IL-6, and TNFalpha by human peripheral blood mononuclear cells. We have now investigated the signal transduction pathway involved in the elicitation of these immunomodulating properties on isolated human monocytes.
Our results show that active peptide Pa provoked phosphoinositide hydrolysis, intracellular calcium elevation, and cAMP accumulation. Herbimycin A, an inhibitor of protein tyrosine kinases (PTK), markedly reduced these effects of peptide Pa. We have also found that this peptide stimulated CREB, NF-kappaB, and AP-1 DNA-binding activity.
With the help of inhibitors of PTK (herbimycin A), phospholipase C (neomycin sulfate), protein kinase C (bis-indolyl maleimide), protein kinase A (H89), and the calmodulin antagonist W-7, as well as cholera toxin, an agent that increases intracellular cAMP, we showed that cytokine (IL-1alpha, IL-1-beta, IL-6, and TNFalpha) production could be modified by the signal transduction pathway triggered by peptide Pa on monocytes.
CITAÇÃO DO ARTIGO Arch Biochem Biophys. 1997 Feb 15;338(2):136-42
A Clínica é o hospital privado com maiores recursos tecnológicos de Espanha, tudo num único centro.
Os profissionais da Clínica realizam um trabalho contínuo de investigação e formação, sempre em benefício do paciente.
Conheça porque é que somos diferentes em relação a outros centros sanitários. Qualidade, rapidez, comodidade e resultados.